USE OF MICROARRAY APPLICATIONS IN NICHE MARKETS RAISES REVENUE OPPORTUNITIES

The use of DNA microarray technology continues to expand into niche markets, such as diagnostics, and that expansion is expected to dramatically increase the number of experiments conducted, resulting in heightened revenues for the total market, according to analysts Frost & Sullivan.

The report, "U.S. DNA Microarrays Markets," reveals that DNA microarrays markets earned revenue of $446.8 million in 2005 and are estimated to reach $532.1 million in 2012.

"The DNA microarray market has experienced a shift from homebrew to commercial microarray method," notes Frost & Sullivan Industry Manager Jessica Shah. "Scientists traditionally using homebrew methods are moving towards commercial technology for higher sensitivity results."